Adjuvant chemotherapy of breast cancer
Qinqin Wu, Fuxiang Zhou
Abstract
Qinqin Wu, Fuxiang Zhou
Abstract
Clinical studies confirm that postoperative adjuvant chemotherapy could significantly reduce mortality rate of patients with the operable breast cancer and improve surviral rate. At present, adjuvant chemotherapy of breast cancer is developing for the direction of high specificity, more efficiency and low toxicity. Individualized and standardized comprehensive treatment which based on molecular genetic analysis is the direction of adjuvant chemotherapy of breast cancer. Key words: Breast neoplasms; Chemotherapy; Adjuvant chemotherapy
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Clinical studies confirm that postoperative adjuvant chemotherapy could significantly reduce mortality rate of patients with the operable breast cancer and improve surviral rate. At present, adjuvant chemotherapy of breast cancer is developing for the direction of high specificity, more efficiency and low toxicity. Individualized and standardized comprehensive treatment which based on molecular genetic analysis is the direction of adjuvant chemotherapy of breast cancer. Key words: Breast neoplasms; Chemotherapy; Adjuvant chemotherapy
Key concepts: Adjuvant, Medicine, Breast cancer, Chemotherapy, Oncology, Adjuvant chemotherapy, Internal medicine, Cancer